ATE323497T1 - Idraparinux (sanorg 34006) zur behandlung und sekundärprophylaxe von thromboembolien bei patienten mit tiefer venenthrombose - Google Patents

Idraparinux (sanorg 34006) zur behandlung und sekundärprophylaxe von thromboembolien bei patienten mit tiefer venenthrombose

Info

Publication number
ATE323497T1
ATE323497T1 AT03702514T AT03702514T ATE323497T1 AT E323497 T1 ATE323497 T1 AT E323497T1 AT 03702514 T AT03702514 T AT 03702514T AT 03702514 T AT03702514 T AT 03702514T AT E323497 T1 ATE323497 T1 AT E323497T1
Authority
AT
Austria
Prior art keywords
sanorg
idraparinux
thromboembolism
patients
treatment
Prior art date
Application number
AT03702514T
Other languages
German (de)
English (en)
Inventor
Amsterdam Ronald Gijsbertu Van
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of ATE323497T1 publication Critical patent/ATE323497T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024Esters of saccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT03702514T 2002-01-29 2003-01-23 Idraparinux (sanorg 34006) zur behandlung und sekundärprophylaxe von thromboembolien bei patienten mit tiefer venenthrombose ATE323497T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02075374 2002-01-29

Publications (1)

Publication Number Publication Date
ATE323497T1 true ATE323497T1 (de) 2006-05-15

Family

ID=27635850

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03702514T ATE323497T1 (de) 2002-01-29 2003-01-23 Idraparinux (sanorg 34006) zur behandlung und sekundärprophylaxe von thromboembolien bei patienten mit tiefer venenthrombose

Country Status (22)

Country Link
US (1) US7709463B2 (enExample)
EP (1) EP1471924B1 (enExample)
JP (1) JP4870907B2 (enExample)
CN (1) CN1622813A (enExample)
AR (1) AR038320A1 (enExample)
AT (1) ATE323497T1 (enExample)
AU (1) AU2003205664B2 (enExample)
BR (1) BR0307196A (enExample)
CA (1) CA2472957C (enExample)
CY (1) CY1107661T1 (enExample)
DE (1) DE60304678T2 (enExample)
DK (1) DK1471924T3 (enExample)
EA (1) EA007204B1 (enExample)
ES (1) ES2262971T3 (enExample)
MX (1) MXPA04007310A (enExample)
NO (1) NO332699B1 (enExample)
PE (1) PE20030855A1 (enExample)
PL (1) PL207144B1 (enExample)
PT (1) PT1471924E (enExample)
SI (1) SI1471924T1 (enExample)
TW (1) TWI281861B (enExample)
WO (1) WO2003063881A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008521903A (ja) * 2004-12-01 2008-06-26 オーエスアイ・ファーマスーティカルズ・インコーポレーテッド N置換されたベンズイミダゾリルC−kit阻害剤及びコンビナトリアルベンゾイミダゾールライブラリー
US9642822B2 (en) 2011-05-27 2017-05-09 Children's Medical Center Corporation Methods for treating and preventing neutrophil-derived net toxicity and thrombosis
BR112022000255A8 (pt) 2019-07-09 2022-03-22 Optimvia Llc Métodos para sintetizar polissacarídeos anticoagulantes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378829A (en) * 1990-04-23 1995-01-03 Akzo N.V. Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type

Also Published As

Publication number Publication date
NO20043195L (no) 2004-10-29
US20050209175A1 (en) 2005-09-22
EA200400817A1 (ru) 2005-02-24
EA007204B1 (ru) 2006-08-25
PT1471924E (pt) 2006-09-29
TWI281861B (en) 2007-06-01
CA2472957A1 (en) 2003-08-07
CY1107661T1 (el) 2013-04-18
MXPA04007310A (es) 2004-10-29
EP1471924A1 (en) 2004-11-03
DE60304678D1 (de) 2006-05-24
PL370557A1 (en) 2005-05-30
CA2472957C (en) 2011-09-13
HK1072361A1 (en) 2005-08-26
WO2003063881A1 (en) 2003-08-07
US7709463B2 (en) 2010-05-04
BR0307196A (pt) 2004-11-03
AR038320A1 (es) 2005-01-12
ES2262971T3 (es) 2006-12-01
PL207144B1 (pl) 2010-11-30
AU2003205664B2 (en) 2008-06-05
SI1471924T1 (sl) 2006-10-31
PE20030855A1 (es) 2003-10-11
DE60304678T2 (de) 2007-04-05
EP1471924B1 (en) 2006-04-19
CN1622813A (zh) 2005-06-01
DK1471924T3 (da) 2006-08-21
NO332699B1 (no) 2012-12-10
JP4870907B2 (ja) 2012-02-08
JP2005519919A (ja) 2005-07-07
TW200302104A (en) 2003-08-01

Similar Documents

Publication Publication Date Title
DE60222671D1 (de) Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
EP1438054A4 (en) METHODS AND COMPOSITIONS FOR TREATING FLAVIVIRUS AND PESTIVIRUS USING MODIFIED NUCLEOSIDE AT 4 'POSITION
DE50214540D1 (de) Stanz bei der behandlung von wunden
DE60108080D1 (de) Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen
DE60327622D1 (de) Kombinierte antitachykardie - schrittmacher und hochspannungstherapie zur behandlung von ventrikulären arrhythmien
ATE350375T1 (de) 17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen- abhängigen erkrankungen
DE60223715D1 (de) Glyt1 transporter inhibitoren und deren anwendung in der behandlung von neurologischen und neuropsychiatischen krankheiten
ATE389649T1 (de) Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen
ATE319453T1 (de) Reboxetin zur behandlung von fibromyalgie und anderen somatoformen störungen
IS8127A (is) Aðferðir og samsetningar sem nýta ónæmistemprandiefnasambönd í meðferð og umönnun á krabba og öðrum sjúkdómum
ATE542801T1 (de) Zur behandlung von neoplastischen krankheiten, entzündlichen erkrankungen und erkrankungen des immunsystems geeignete 2,4-pyrimidindiamine
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
DE50212701D1 (de) Bestrahlungsanordnung zur behandlung von akne und aknenarben
ATE381347T1 (de) Kombinationen von ezetimibe und aspirin zur behandlung von kardiovaskulären erkrankungen
EP1416957A4 (en) TREATMENT OF DISORDERS RELATING TO IMMUNE CELLS AND B CELLS
DE60206289D1 (de) Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne
DE60321669D1 (de) Co-perlchen von dha und rosmarin und verwendungsverfahren
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
ZA200500719B (en) The use of the combination of ciclesonide and antihitamines for the treatment of allergic rhinitis.
DE60136748D1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
DE60224004D1 (de) Verwendung von il-18 hemmern zur behandlung und/oder prävention von herzkrankheiten
DE60233740D1 (de) Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit
EE200400074A (et) Koostised ning nende kasutamine proliferatiivsetehaiguste raviks
ATE347888T1 (de) Verwendung von aivlosin zur behandlung und prevention der lawsonia-infektionen in schweinen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1471924

Country of ref document: EP